Brca2Deficiency Sensitizes Cells to PARP Inhibition

Cancer Research - United States
doi 10.1158/0008-5472.can-66-1-cor
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

PARP Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2018English

PARP Inhibition Sensitizes P53-Deficient Breast Cancer Cells to Doxorubicin-Induced Apoptosis

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2005English

Reduced PAK1 Activity Sensitizes FA/BRCA-proficient Breast Cancer Cells to PARP Inhibition

Oncotarget
Oncology
2016English

Targeting HSF1 Sensitizes Cancer Cells to HSP90 Inhibition

Oncotarget
Oncology
2013English

Simultaneous Activation and Inhibition of Autophagy Sensitizes Cancer Cells to Chemotherapy

Oncotarget
Oncology
2016English

PARP Inhibitor Re‑sensitizes Adriamycin Resistant Leukemia Cells Through DNA Damage and Apoptosis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Loss of NFBD1/MDC1 Disrupts Homologous Recombination Repair and Sensitizes Nasopharyngeal Carcinoma Cells to PARP Inhibitors

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2019English

Autophagy Inhibition Sensitizes Colon Cancer Cells to Antiangiogenic and Cytotoxic Therapy

Clinical Cancer Research
Cancer ResearchOncology
2013English

Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin

2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy